Lv71
5000 积分 2022-03-07 加入
Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial
1个月前
已完结
Radiation as an immune modulator: mechanisms and implications for combination with immunotherapy
1个月前
已完结
Preclinical Characterization and Clinical Activity of RNK08954, a Highly Selective and Orally Bioavailable KRAS G12D Inhibitor
1个月前
已完结
CDCP1在恶性肿瘤中的功能及其研究进展
1个月前
已完结
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy
1个月前
已完结
An overview of KRAS-targeting therapies for colorectal cancer in phase I and II development
1个月前
已完结
万妥单抗临床使用及不良反应管理专家共识（2025版）
2个月前
已完结
Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled Trial
2个月前
已完结
Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRASG12C mutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trials
2个月前
已完结
皖公网安备34019202002308
